Response to: MiniMed 780G System Outperforms Other Automated Insulin Systems Due to Algorithm Design, Not Bias-Response to Inaccurate Allegations.
Forlenza GP, Sherr JL. Response to: MiniMed 780G System Outperforms Other Automated Insulin Systems Due to Algorithm Design, Not Bias-Response to Inaccurate Allegations. Diabetes Technol Ther. 2024 Oct; 26(10):785-786.